ImmunoScape Information

ImmunoScape is transforming cancer therapy with its novel Seed-and-Boost approach, which combines our proprietary optimised TCR T cells with clinically-validated Immuno-STAT T cell engagers. This pioneering approach addresses the shortcomings of current cell therapies by enabling potent in vivo expansion of infused tumor targeting T-cells. Our combination therapy has the potential to transform cell therapy, through the delivery of safe, tolerable and effective therapies against cancer while simplifying the patient journey. We are currently advancing IND-enabling studies and accelerating entry into the clinic.